Mengmeng Lu
P.R. China
Xuzhou, China
Xuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Herpes Virus Entry Mediator Costimulation Signaling Enhances CAR T-cell Efficacy Against Solid Tumors Through Metabolic Reprogramming.
Journal: Cancer immunology research
Published: July 04, 2022
Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity.
Journal: Frontiers in oncology
Published: February 03, 2021
Profiling prokaryotic community in pit mud of Chinese strong-aroma type liquor by using oligotrophic culturing.
Journal: International journal of food microbiology
Published: March 11, 2020
CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: October 02, 2019
Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy.
Journal: American journal of cancer research
Published: September 03, 2019
Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells.
Journal: American journal of cancer research
Published: January 22, 2019
Corrigendum to "Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models".
Journal: Journal of immunology research
Published: December 23, 2018
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models.
Journal: Journal of immunology research
Published: April 19, 2018
Bortezomib improves adoptive carbonic anhydrase IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma.
Journal: Oncology reports
Published: March 07, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026